vs
Apellis Pharmaceuticals, Inc.（APLS）与1 800 FLOWERS COM INC（FLWS）财务数据对比。点击上方公司名可切换其他公司
1 800 FLOWERS COM INC的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍（$293.0M vs $199.9M），Apellis Pharmaceuticals, Inc.净利率更高（-29.5% vs -34.1%，领先4.7%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -11.6%），1 800 FLOWERS COM INC自由现金流更多（$20.0M vs $-14.3M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -12.1%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
1 800 FLOWERS COM INC是美国知名的全渠道鲜花礼品零售企业，主营鲜花花束、礼品篮、美食礼盒、定制礼物及家居装饰品，服务北美地区个人及企业客户，覆盖节日、生日、纪念日等各类送礼场景。
APLS vs FLWS — 直观对比
营收规模更大
FLWS
是对方的1.5倍
$199.9M
营收增速更快
APLS
高出5.7%
-11.6%
净利率更高
APLS
高出4.7%
-34.1%
自由现金流更多
FLWS
多$34.3M
$-14.3M
两年增速更快
APLS
近两年复合增速
-12.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $293.0M |
| 净利润 | $-59.0M | $-100.1M |
| 毛利率 | — | 33.2% |
| 营业利润率 | -25.6% | 34.5% |
| 净利率 | -29.5% | -34.1% |
| 营收同比 | -5.9% | -11.6% |
| 净利润同比 | -62.2% | 44.3% |
| 每股收益（稀释后） | $-0.40 | $-1.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSFLWS
| Q1 26 | — | $293.0M | ||
| Q4 25 | $199.9M | $702.2M | ||
| Q3 25 | $458.6M | $215.2M | ||
| Q2 25 | $178.5M | $336.6M | ||
| Q1 25 | $166.8M | $331.5M | ||
| Q4 24 | $212.5M | $775.5M | ||
| Q3 24 | $196.8M | $242.1M | ||
| Q2 24 | $199.7M | — |
净利润APLSFLWS
| Q1 26 | — | $-100.1M | ||
| Q4 25 | $-59.0M | $70.6M | ||
| Q3 25 | $215.7M | $-53.0M | ||
| Q2 25 | $-42.2M | $-51.9M | ||
| Q1 25 | $-92.2M | $-178.2M | ||
| Q4 24 | $-36.4M | $64.3M | ||
| Q3 24 | $-57.4M | $-34.2M | ||
| Q2 24 | $-37.7M | — |
毛利率APLSFLWS
| Q1 26 | — | 33.2% | ||
| Q4 25 | — | 42.1% | ||
| Q3 25 | — | 35.7% | ||
| Q2 25 | — | 35.5% | ||
| Q1 25 | — | 31.7% | ||
| Q4 24 | — | 43.3% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | — | — |
营业利润率APLSFLWS
| Q1 26 | — | 34.5% | ||
| Q4 25 | -25.6% | 10.6% | ||
| Q3 25 | 48.7% | -23.5% | ||
| Q2 25 | -18.6% | -16.5% | ||
| Q1 25 | -50.0% | -58.4% | ||
| Q4 24 | -12.3% | 11.7% | ||
| Q3 24 | -24.0% | -19.4% | ||
| Q2 24 | -14.7% | — |
净利率APLSFLWS
| Q1 26 | — | -34.1% | ||
| Q4 25 | -29.5% | 10.0% | ||
| Q3 25 | 47.0% | -24.6% | ||
| Q2 25 | -23.6% | -15.4% | ||
| Q1 25 | -55.3% | -53.8% | ||
| Q4 24 | -17.1% | 8.3% | ||
| Q3 24 | -29.2% | -14.1% | ||
| Q2 24 | -18.9% | — |
每股收益（稀释后）APLSFLWS
| Q1 26 | — | $-1.56 | ||
| Q4 25 | $-0.40 | $1.10 | ||
| Q3 25 | $1.67 | $-0.83 | ||
| Q2 25 | $-0.33 | $-0.80 | ||
| Q1 25 | $-0.74 | $-2.80 | ||
| Q4 24 | $-0.30 | $1.00 | ||
| Q3 24 | $-0.46 | $-0.53 | ||
| Q2 24 | $-0.30 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $50.7M |
| 总债务越低越好 | — | $24.0M |
| 股东权益账面价值 | $370.1M | $192.5M |
| 总资产 | $1.1B | $679.9M |
| 负债/权益比越低杠杆越低 | — | 0.12× |
8季度趋势，按日历期对齐
现金及短期投资APLSFLWS
| Q1 26 | — | $50.7M | ||
| Q4 25 | $466.2M | $193.3M | ||
| Q3 25 | $479.2M | $7.7M | ||
| Q2 25 | $370.0M | $46.5M | ||
| Q1 25 | $358.4M | $84.7M | ||
| Q4 24 | $411.3M | $247.2M | ||
| Q3 24 | $396.9M | $8.4M | ||
| Q2 24 | $360.1M | — |
总债务APLSFLWS
| Q1 26 | — | $24.0M | ||
| Q4 25 | — | $123.5M | ||
| Q3 25 | — | $128.9M | ||
| Q2 25 | — | $134.8M | ||
| Q1 25 | — | $142.3M | ||
| Q4 24 | — | $157.5M | ||
| Q3 24 | — | $172.3M | ||
| Q2 24 | — | — |
股东权益APLSFLWS
| Q1 26 | — | $192.5M | ||
| Q4 25 | $370.1M | $289.7M | ||
| Q3 25 | $401.2M | $217.5M | ||
| Q2 25 | $156.3M | $268.3M | ||
| Q1 25 | $164.2M | $317.7M | ||
| Q4 24 | $228.5M | $495.1M | ||
| Q3 24 | $237.1M | $433.4M | ||
| Q2 24 | $264.3M | — |
总资产APLSFLWS
| Q1 26 | — | $679.9M | ||
| Q4 25 | $1.1B | $893.1M | ||
| Q3 25 | $1.1B | $840.5M | ||
| Q2 25 | $821.4M | $772.6M | ||
| Q1 25 | $807.3M | $806.2M | ||
| Q4 24 | $885.1M | $1.1B | ||
| Q3 24 | $901.9M | $1.0B | ||
| Q2 24 | $904.5M | — |
负债/权益比APLSFLWS
| Q1 26 | — | 0.12× | ||
| Q4 25 | — | 0.43× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $42.9M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $20.0M |
| 自由现金流率自由现金流/营收 | -7.1% | 6.8% |
| 资本支出强度资本支出/营收 | 0.1% | 7.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $140.5M |
8季度趋势，按日历期对齐
经营现金流APLSFLWS
| Q1 26 | — | $42.9M | ||
| Q4 25 | $-14.2M | $309.9M | ||
| Q3 25 | $108.5M | $-139.0M | ||
| Q2 25 | $4.4M | $-27.1M | ||
| Q1 25 | $-53.4M | $-150.6M | ||
| Q4 24 | $19.4M | $328.5M | ||
| Q3 24 | $34.1M | $-177.2M | ||
| Q2 24 | $-8.3M | — |
自由现金流APLSFLWS
| Q1 26 | — | $20.0M | ||
| Q4 25 | $-14.3M | $302.2M | ||
| Q3 25 | $108.3M | $-145.6M | ||
| Q2 25 | $4.4M | $-36.1M | ||
| Q1 25 | $-53.4M | $-160.0M | ||
| Q4 24 | $19.3M | $317.6M | ||
| Q3 24 | — | $-189.3M | ||
| Q2 24 | $-8.4M | — |
自由现金流率APLSFLWS
| Q1 26 | — | 6.8% | ||
| Q4 25 | -7.1% | 43.0% | ||
| Q3 25 | 23.6% | -67.7% | ||
| Q2 25 | 2.5% | -10.7% | ||
| Q1 25 | -32.0% | -48.3% | ||
| Q4 24 | 9.1% | 41.0% | ||
| Q3 24 | — | -78.2% | ||
| Q2 24 | -4.2% | — |
资本支出强度APLSFLWS
| Q1 26 | — | 7.8% | ||
| Q4 25 | 0.1% | 1.1% | ||
| Q3 25 | 0.0% | 3.1% | ||
| Q2 25 | 0.0% | 2.7% | ||
| Q1 25 | 0.0% | 2.8% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.0% | 5.0% | ||
| Q2 24 | 0.0% | — |
现金转化率APLSFLWS
| Q1 26 | — | — | ||
| Q4 25 | — | 4.39× | ||
| Q3 25 | 0.50× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 5.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
FLWS
| Consumer Floral & Gifts | $159.4M | 54% |
| Gourmet Foods & Gift Baskets | $106.9M | 36% |
| BloomNet | $26.9M | 9% |
| Corporate | $50.0K | 0% |
